Modulation of Retinoic Acid Receptor Subtypes by 5- and 8-Substituted (Naphthalen-2-yl)-based Arotinoids.

Author: GronemeyerHinrich, KhanwalkarHarshal, LiebMichele, MartínezClaudio, Rodríguez-BarriosFátima, de LeraAngel R, ÁlvarezRosana, ÁlvarezSusana

Paper Details 
Original Abstract of the Article :
Retinoid receptors (RARs and RXRs) transduce the signals of their natural and synthetic ligands (retinoids and rexinoids) to cellular transcriptional machinery to induce gene programs that control diverse biological and physiological effects on organisms. All-trans-retinoic acid, the natural ligand ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1002/cmdc.201500150

データ提供:米国国立医学図書館(NLM)

Arotinoids: Modulating Retinoid Receptors for Therapeutic Potential

This study focuses on the fascinating world of [retinoid receptors] and their role in [gene regulation]. The authors investigated the [modulatory effects] of a new series of [arotinoids] on [retinoic acid receptor (RAR) subtypes]. They used [in vitro transactivation studies] to assess the ability of these compounds to activate or inhibit different RAR subtypes.

The study revealed that [the new arotinoids] exhibited [selective activity] towards different RAR subtypes. Some compounds acted as [RARβ agonists], while others exhibited [dual RARβ/RARα antagonist] activity. These findings demonstrate the potential of [arotinoids] to be [effective therapeutic agents] for various conditions, including [acute promyelocytic leukemia] and [cutaneous T-cell lymphoma].

Targeted Therapy for Retinoid Receptor-Related Diseases

This research demonstrates the promise of [arotinoids] as [targeted therapies] for [retinoid receptor-related diseases]. It’s like having a key that unlocks specific doors in the complex machinery of the body. By understanding the [selective activity] of different [arotinoids], researchers can develop more [effective and targeted treatments] for a variety of diseases.

The Potential of Arotinoids in Disease Treatment

This study opens new avenues for [drug development] targeting [retinoid receptors]. It’s like finding a hidden oasis in the desert of [retinoid research], offering a potential source of healing and relief. Further research is needed to fully understand the therapeutic potential of these compounds and their impact on human health.

Dr.Camel's Conclusion

This study investigates the effects of a new series of arotinoids on different retinoid receptor subtypes. The findings demonstrate the potential of these compounds to act as agonists or antagonists for specific receptors, suggesting their potential as targeted therapies for various conditions. This research highlights the importance of understanding the complex interactions between retinoid receptors and their ligands for developing effective treatments for a variety of diseases. It's like uncovering a secret passageway in the vast desert of drug discovery, leading to new possibilities for therapeutic solutions.

Date :
  1. Date Completed 2016-04-21
  2. Date Revised 2016-11-25
Further Info :

Pubmed ID

26012882

DOI: Digital Object Identifier

10.1002/cmdc.201500150

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.